α-Glucosidase-IN-13
α-Glucosidase-IN-13 (Compound 8) is a α-glucosidase inhibitor with an IC50 of 5.69 μM[1].
Product Specifications
CAS Number
[2816072-18-9]
UNSPSC
12352005
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/α-glucosidase-in-13.html
Solubility
10 mM in DMSO
Smiles
O=C(NN1C(C2=CC=C(C=O)C=C2)SCC1=O)CN3C(SCCCCCC)=NC4=CC=CC=C34
Molecular Formula
C25H28N4O3S2
Molecular Weight
496.64
References & Citations
[1]Khan S A, et al. Mercaptobenzimidazole-Based 1, 3-Thaizolidin-4-ones as Antidiabetic Agents: Synthesis, In Vitro α-Glucosidase Inhibition Activity, and Molecular Docking Studies. ACS Omega, 2022.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
124028-ML550 100 µL
BTBD1 (BTB/POZ Domain-containing Protein 1, Hepatitis C Virus NS5A-transactivated Protein 8, HCV NS5A-transactivated Protein 8, C15orf1, NS5ATP8) (MaxLight 550)
Ask
View Details